4.4 Review

Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status

Journal

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 37, Issue 2, Pages 99-112

Publisher

SPRINGER
DOI: 10.1007/s40618-013-0019-8

Keywords

Pituitary tumors; Prolactinomas; Acromegaly; Cushing's disease; Non-functioning pituitary adenomas; Fertility; Pregnancy

Funding

  1. Ferring
  2. Lilly
  3. Ipsen
  4. Merck-Serono
  5. Novartis
  6. Novo-Nordisk
  7. Pfizer
  8. Viro-pharma
  9. IBSA

Ask authors/readers for more resources

Pregnancy is becoming a relatively common event in patients with pituitary tumors (PT), due to the increasing availability of medical treatments, which control pituitary diseases associated with the development of PT. However, the presence of PT and its treatment may be a disturbing factor for pregnancy, and pregnancy significantly influences the course and the management of PT. This review summarizes the knowledge about the management of PT during pregnancy and the occurrence of pregnancy in patients with pre-existent PT, focusing on secreting PT characterized by hormonal excess and on clinically non-functioning PT often associated to hormone deficiency, which configure the hypopituitaric syndrome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available